By Allissa Wickham ( November 10, 2014, 5:06 PM EST) -- AstraZeneca PLC and two generic-drug makers asked a Massachusetts federal court on Monday for judgment on all claims in a pay-for-delay case over the heartburn treatment Nexium, arguing that the plaintiffs hadn't shown that a $9 million deal in a separate patent suit constituted a large, unjustified payment....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.